Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel Monotherapy in Acute Schizophrenia
NCT00428350Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in schizophrenia, sponsored by AstraZeneca. Started Dec 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00428350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428350.